EyeCRO, MPI Research partner on large mammalian preclinical models
EyeCRO and MPI Research are co-developing large mammalian preclinical models for ophthalmic diseases as clients look to perform pharmacology studies in larger species.
Archives for May 1, 2017
Gene therapy no longer science fiction: IRB launches biosafety committee service
Schulman IRB has launched a new service to ensure sponsors, CROs, and others are compliant when conducting genetic engineering research – “given the diverse risks,” says committee lead.
NIH award emphasizes long-term relationship, says AMRI
AMRI has received a 5-year federal contract award from the National Institutes of Health (NIH) under which it will provide drug substance development and manufacturing services.
Dr Reddy's: No production halt at Bachupally plant hit with Form 483
The US FDA has identified problems at Dr Reddy’s generic drug manufacturing site in Bachupally, India according to a filing on the Bombay Stock Exchange (BSE).
BPI Europe 2017
Roche on excipient inconsistencies: ‘Don’t blame suppliers, work with them’
An inconsistent lot of excipient Poloxamer 188 cut biologic yield 30%, but working with supplier BASF was key to prevent future problems, according to Roche.
Romaco's PE owner sells majority of stake to China-based Truking
Romaco GmbH owner DBAG has sold most of its stake in the processing technology firm to Truking Group.
AMRI says it is well placed to win more NCATS contracts
AMRI gets 5-year NIH API manufacturing and process dev contract
AMRI has been hired by the NIH to provide synthesis and manufacturing services for APIs being developed by the National Center for Advancing Translational Sciences (NCATS) division of preclinical innovation.